Retrospective analysis of different regimens for Chinese adults with severe newly diagnosed immune thrombocytopenia.,Clinical and Experimental Medicine

当前位置： X-MOL 学术 › Clin. Exp. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Retrospective analysis of different regimens for Chinese adults with severe newly diagnosed immune thrombocytopenia.
Clinical and Experimental Medicine ( IF 4.6 ) Pub Date : 2020-05-26 , DOI: 10.1007/s10238-020-00630-7
Xiaoyue Wang ₁ , Yan Xu ₂ , Weiwei Gui ₁ , Feng Hui ₁ , Hui Liao ₁

Affiliation

To review the efficacy and safety of glucocorticoids combined with different regimens for treating severe immune thrombocytopenia (ITP). Eighty-five severe ITP patients from 2 tertiary hospitals treated with glucocorticoids were enrolled from January 2018 to May 2019 and divided into 4 treatment groups: group A (treated with glucocorticoids), group B (glucocorticoids plus intravenous immunoglobulin (IVIg)), group C (glucocorticoids plus recombinant human thrombopoietin (rhTPO)), and group D (glucocorticoids plus IVIg and rhTPO). Statistical analysis was performed with SPSS 19.0 software. Early responses and response maintenance were assessed at 14 days and 1 month after treatment. Groups B, C and D had higher complete response (CR) and overall response (OR) rates than group A (P < 0.05). Adverse reaction incidences were not significantly different among all groups (P > 0.05). Severe ITP patients who received glucocorticoids with IVIg and rhTPO had higher CRs and ORs at the platelet level, and no significant adverse reactions were observed. Glucocorticoids combined with different regimens had different clinical efficacies for treating severe ITP.

更新日期：2020-05-26

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>